Clinical Trial Update: A 3D Bioprinted Hormone-producing Model for BRCA Mutated Patients After Risk Reducing Surgery: the DISC-OVARY Trial [NA]

View source ↗

Summary

This document provides an update on the DISC-OVARY trial, which investigates a 3D bioprinted hormone-producing model for BRCA mutation carriers after risk-reduc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: BRCA Mutation, Estrogen Deficiency | NA | Status: ACTIVE_NOT_RECRUITING